ArticleFrontiers in pharmacology2023

Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity.

Jianbo He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.